| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 84.196 | 131.130 | 40.646 | 11.155 | 3.512 | 99.895 | 27.460 |
| Total Income - EUR | 0 | 0 | 0 | 84.254 | 131.139 | 40.646 | 11.155 | 3.512 | 99.896 | 27.496 |
| Total Expenses - EUR | 0 | 0 | 0 | 57.012 | 80.286 | 35.164 | 13.177 | 5.643 | 97.342 | 27.440 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 27.242 | 50.853 | 5.482 | -2.022 | -2.131 | 2.555 | 56 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 26.377 | 49.632 | 5.153 | -2.157 | -2.236 | 1.752 | -219 |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Lemar Bio Industry S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.879 | 1.859 | 1.828 | 1.645 | 3.129 | 30.732 | 29.407 | 29.498 | 25.994 | 25.849 |
| Current Assets | 551 | 546 | 536 | 46.800 | 54.945 | 35.200 | 34.265 | 52.404 | 34.462 | 30.995 |
| Inventories | 0 | 0 | 0 | 7.243 | 20.189 | 21.729 | 20.600 | 20.664 | 16.239 | 16.149 |
| Receivables | 0 | 0 | 0 | 3.369 | 12.729 | 12.528 | 12.314 | 20.468 | 12.357 | 12.359 |
| Cash | 551 | 546 | 536 | 36.188 | 22.027 | 943 | 1.351 | 11.272 | 5.865 | 2.488 |
| Shareholders Funds | 2.430 | 2.405 | 2.364 | 28.698 | 55.592 | 59.691 | 56.210 | 54.149 | 46.946 | 46.464 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 0 | 0 | 0 | 19.747 | 2.482 | 6.241 | 7.461 | 27.753 | 13.510 | 10.380 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1629 - 1629" | |||||||||
| CAEN Financial Year |
1629
|
|||||||||
Comments - Lemar Bio Industry S.r.l.